In one paragraphArticle in Journal of natural products, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Ana G Carrillo-AkéUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0002-9252-4746 José Delgado-DomínguezUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0003-3570-3331 Rocely Buenaventura Cervantes-SarabiaUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0002-4946-8689 Adriana Ruiz-RemigioUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0003-4776-7842 Jaime Zamora-ChimalUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0003-3690-0775 Norma Salaiza-SuazoUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0001-6024-3352 Luis W Torres-TapiaCentro de Investigación Científica de Yucatán (CICY), Unidad de Biotecnología, Calle 43 #130, Col. Chuburná de Hidalgo, Mérida, Yucatán 97205, Mexico.ORCID 0000-0002-6198-9321 Sergio R Peraza-SánchezCentro de Investigación Científica de Yucatán (CICY), Unidad de Biotecnología, Calle 43 #130, Col. Chuburná de Hidalgo, Mérida, Yucatán 97205, Mexico.ORCID 0000-0002-8161-501X Ingeborg BeckerUnidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Balmis 148, Ciudad de México 06720, Mexico.ORCID 0000-0003-3821-4998 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Pentavalent antimonials are the first-line treatment for localized cutaneous leishmaniasis. However, they have disadvantages such as their elevated toxicity, high costs, and parenteral application. Plant-derived compounds may be an alternative treatment against this disease. Previous
Indexed as
Antiprotozoal AgentsLeishmania mexicanaLeishmaniasis, CutaneousAdministration, TopicalAnimalsApoptosisMacrophagesMiceMice, Inbred C57BLMolecular StructureReactive Oxygen SpeciesAntiprotozoal AgentsReactive Oxygen Species
Identifiers
PMID40179055
PMCPMC12038837
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390